Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Membranes|November 27, 2021
Surface Characterization of Lipid Biomimetic SystemsAnibal Disalvo, Maria A FriasTrends in Endocrinology and Metabolism: TEM|February 2, 2023
Regulation of mTOR by phosphatidic acidMaria A Frias, Ahmet Hatipoglu, David A FosterThe Journal of Biological Chemistry|July 4, 2014
Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR)David A Foster, Darin Salloum, Deepak Menon, et al.Cancer Letters|September 26, 2021
Cancer cells with defective RB and CDKN2A are resistant to the apoptotic effects of rapamycinSohag Chakraborty, Matthew B Utter, Maria A Frias, et al.Molecular Cancer Therapeutics|February 27, 2016
The Enigma of Rapamycin DosageSuman Mukhopadhyay, Maria A Frias, Amrita Chatterjee, et al.Plos One|October 21, 2022
Inhibiting glutamine utilization creates a synthetic lethality for suppression of ATP citrate lyase in KRas-driven cancer cellsAhmet Hatipoglu, Deepak Menon, Talia Levy, et al.The Journal of Biological Chemistry|January 31, 2015
Reciprocal regulation of AMP-activated protein kinase and phospholipase DSuman Mukhopadhyay, Mahesh Saqcena, Amrita Chatterjee, et al.The Journal of Biological Chemistry|September 9, 2018
Phospholipase D-dependent mTOR complex 1 (mTORC1) activation by glutamineElyssa Bernfeld, Deepak Menon, Vishaldeep Vaghela, et al.The Journal of Biological Chemistry|November 27, 2019
Phosphatidic acid drives mTORC1 lysosomal translocation in the absence of amino acidsMaria A Frias, Suman Mukhopadhyay, Elyssa Lehman, et al.Current Biology : CB|August 22, 2006
mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2sMaria A Frias, Carson C Thoreen, Jacob D Jaffe, et al.Pageof 2